Erratum: Application of High-Sensitivity Troponin in Suspected Myocardial Infarction (New England Journal of Medicine (2019) 380 (2529-2540) DOI: 10.1056/NEJMoa1803377);Application of high-sensitivity troponin in suspected myocardial infarction

New England Journal of Medicine

Volumn 380, Issue 26, 2019, Pages 2529-2540

  Neumann, Johannes T ^a,b   Twerenbold, Raphael ^a,l   Ojeda, Francisco ^a   Sörensen, Nils A ^a,b   Chapman, Andrew R ^m   Shah, Anoop S V ^m,n   Anand, Atul ^m   Boeddinghaus, Jasper ^l   Nestelberger, Thomas ^l   Badertscher, Patrick ^l   Mokhtari, Arash ^r   Pickering, John W ^v   Troughton, Richard W ^v   Greenslade, Jaimi ^w,x   Parsonage, William ^w,x   Mueller Hennessen, Matthias ^b,d   Gori, Tommaso ^e   Jernberg, Tomas ^s   Morris, Niall ^o   Liebetrau, Christoph ^h,i   Hamm, Christian ^h,i   Katus, Hugo A ^b,d   Münzel, Thomas ^e   Landmesser, Ulf ^j   Salomaa, Veikko ^y   Iacoviello, Licia ^z,aa   Ferrario, Marco M ^aa   Giampaoli, Simona ^ab   Kee, Frank ^p   Thorand, Barbara ^k   Peters, Annette ^b,k   Borchini, Rossana ^aa   Jørgensen, Torben ^ac,ad,ae   Söderberg, Stefan ^t   Sans, Susana ^af   Tunstall Pedoe, Hugh ^q   Kuulasmaa, Kari ^y   Renné, Thomas ^c   Lackner, Karl J ^g   Worster, Andrew ^ag   Body, Richard ^o   Ekelund, Ulf ^r   Kavsak, Peter A ^ah   Keller, Till ^h   Lindahl, Bertil ^u   Wild, Philipp ^f,g   Giannitsis, Evangelos ^b,d   Than, Martin ^v   Cullen, Louise A ^w,x   Mills, Nicholas L ^m,n   Mueller, Christian ^l   Zeller, Tanja ^a,b   Westermann, Dirk ^a,b   Blankenberg, Stefan ^a,b   more..

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e Cardiology I   (Germany)

^f Preventive Cardiology and Preventive Medicine Center for Cardiology   (Germany)

^g UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^h Partner Site Rhine Main   (Germany)

ⁱ JUSTUS LIEBIG UNIVERSITY   (Germany)

^j BERLIN INSTITUTE OF HEALTH   (Germany)

^k INSTITUTE OF EPIDEMIOLOGY   (Germany)

^l UNIVERSITY HOSPITAL BASEL   (Switzerland)

^m KING'S COLLEGE LONDON   (United Kingdom)

ⁿ Usher Institute of Population Health Sciences and Informatics   (United Kingdom)

^o UNIVERSITY OF EDINBURGH   (United Kingdom)

^p QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^q UNIVERSITY OF DUNDEE   (United Kingdom)

^r LUND UNIVERSITY   (Sweden)

^s DANDERYD HOSPITAL   (Sweden)

^t UMEÅ UNIVERSITY   (Sweden)

^u UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

^v UNIVERSITY OF OTAGO   (New Zealand)

^w Women's Hospital Radiology Department   (Australia)

^x QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^y NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^z IRCCS NEUROMED   (Italy)

^aa UNIVERSITY OF INSUBRIA   (Italy)

^ab National Health Institute   (Italy)

^ac UNIVERSITY OF COPENHAGEN   (Denmark)

^ad Building 84/85   (Denmark)

^ae AALBORG UNIVERSITY   (Denmark)

^af Generalitat of Catalonia Travessera de les Corts   (Spain)

^ag MCMASTER UNIVERSITY   (Canada)

^ah MCMASTER UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HIGH SENSITIVITY TROPONIN; TROPONIN; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE ASSOCIATION; EMERGENCY WARD; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; PATIENT RISK; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; BLOOD; HOSPITAL EMERGENCY SERVICE; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ADULT; AGED; BIOMARKERS; COHORT STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TROPONIN; TROPONIN I;

EID: 85068262580     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMx220009     Document Type: Erratum

References (26)

1. Niska R, Bhuiya F, Xu J. National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. Natl Health Stat Report 2010;1-31.
2. Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267-315.
3. Westermann D, Neumann JT, Sörensen NA, Blankenberg S. High-sensitivity assays for troponin in patients with cardiac disease. Nat Rev Cardiol 2017;14:472-83.
4. Twerenbold R, Boeddinghaus J, Nestelberger T, et al. Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction. J Am Coll Cardiol 2017;70:996-1012.
5. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
6. Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
7. Chapman AR, Lee KK, McAllister DA, et al. Association of high-sensitivity cardiac troponin I concentration with cardiac outcomes in patients with suspected acute coronary syndrome. JAMA 2017;318:1913-24.
8. Pickering JW, Than MP, Cullen L, et al. Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: a collaborative meta-analysis. Ann Intern Med 2017;166:715-24.
9. Neumann JT, Sörensen NA, Schwemer T, et al. Diagnosis of myocardial infarction using a high-sensitivity troponin I 1-hour algorithm. JAMA Cardiol 2016;1: 397-404.
10. Mueller C, Giannitsis E, Christ M, et al. Multicenter evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann Emerg Med 2016;68(1): 76-87.e4.
11. Rubini Gimenez M, Twerenbold R, Jaeger C, et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am J Med 2015;128(8):861-870.e4.
12. Chapman AR, Anand A, Boeddinghaus J, et al. Comparison of the efficacy and safety of early rule-out pathways for acute myocardial infarction. Circulation 2017;135:1586-96.
13. Keller T, Zeller T, Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011;306:2684-93.
14. Mokhtari A, Borna C, Gilje P, et al. A 1-h combination algorithm allows fast rule-out and rule-in of major adverse cardiac events. J Am Coll Cardiol 2016;67: 1531-40.
15. Kavsak PA, Jaffe AS, Greene DN, Christenson RH, Apple FS, Wu AHB. Total analytic error for low cardiac troponin concentrations (≤10 ng/L) by use of a high-sensitivity cardiac troponin assay. Clin Chem 2017;63:1043-5.
16. Cullen L, Mueller C, Parsonage WA, et al. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol 2013; 62:1242-9.
17. Blankenberg S, Salomaa V, Makarova N, et al. Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. Eur Heart J 2016;37:2428-37.
18. Shortt C, Ma J, Clayton N, et al. Rule-in and rule-out of myocardial infarction using cardiac troponin and glycemic bio-markers in patients with symptoms suggestive of acute coronary syndrome. Clin Chem 2017;63:403-14.
19. Shah AS, Anand A, Sandoval Y, et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 2015;386:2481-8.
20. Than M, Cullen L, Aldous S, et al. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol 2012;59:2091-8.
21. Body R, Carlton E, Sperrin M, et al. Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid: single biomarker re-derivation and external validation in three cohorts. Emerg Med J 2017;34:349-56.
22. Rubini Giménez M, Hoeller R, Reichlin T, et al. Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol 2013;168:3896-901.
23. Zeller T, Hughes M, Tuovinen T, et al. BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries. Eur J Epidemiol 2014;29:777-90.
24. Goldstein SA, Newby LK, Cyr DD, et al. Relationship between peak troponin values and long-term ischemic events among medically managed patients with acute coronary syndromes. J Am Heart Assoc 2017;6(4):e005334.
25. Kavsak PA, Worster A, Hill SA, Mac-Rae AR, Jaffe AS. Analytical comparison of three different versions of a high-sensitivity cardiac troponin I assay over 10 years. Clin Chim Acta 2017;475:51-5.
26. Zeller T, Tunstall-Pedoe H, Saarela O, et al. High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J 2014;35:271-81.